{"id":"doi:10.1038/nrd4591","kind":"review","title":"Combination cancer immunotherapy and new immunomodulatory targets","authors":["Kathleen Margaret Mahoney","Paul D. Rennert","Gordon James Freeman"],"author_count":3,"year":2015,"published":"2015-07-31","venue":"Nature Reviews Drug Discovery","cited_by":1294,"doi":"10.1038/nrd4591","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/nrd4591","archive_url":"https://space-kitty.com/papers/doi:10.1038/nrd4591","updated":null,"pmid":"26228759","pmcid":null,"openalex_id":"W1942897646","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Cancer Immunotherapy and Biomarkers"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}